Lenalidomide is an immunomodulatory drug primarily used in the treatment of multiple myeloma and certain myelodysplastic syndromes, often marketed under the brand name Revlimid. It works by modulating the immune system, inhibiting angiogenesis, and affecting tumor cell proliferation. Due to its potent pharmacological activity and potential for teratogenic effects, ensuring the pharmaceutical purity of Lenalidomide is essential for patient safety, therapeutic consistency, and regulatory standards. Impurity profiling plays a vital role in detecting and controlling unwanted substances that may arise during manufacturing, storage, or degradation. Here are some of its known impurities listed below.
Showing 1 - 4 of 4 products

Catalogue No : LENA-OCL-001
CAS No : 191732-72-6
In Stock
Synonyms
3-(4-Amino-1,3-dihydro-1-oxo-2H-isoindol-2-yl)-2,6-piperidinedione
3-(4-Amino-1,3-dihydro-1-oxo-2H-isoindol-2-yl)-2,6-piperidinedione

Catalogue No : LENA-OCL-002
CAS No : 827026-45-9
In Stock
Synonyms
3-(1,3-Dihydro-4-nitro-1-oxo-2H-isoindol-2-yl)-2,6-piperidinedione ; 3-(4-Nitro-1,3-dihydro-1-oxo-2H-isoindol-2-yl)-2,6-piperidinedione
3-(1,3-Dihydro-4-nitro-1-oxo-2H-isoindol-2-yl)-2,6-piperidinedione ; 3-(4-Nitro-1,3-dihydro-1-oxo-2H-isoindol-2-yl)-2,6-piperidinedione

Catalogue No : LENA-OCL-003
CAS No : 2197414-55-2
In Stock
Synonyms
2-(4-Amino-1-oxoisoindolin-2-yl)pentanediamide
2-(4-Amino-1-oxoisoindolin-2-yl)pentanediamide

Catalogue No : LENA-OCL-004
CAS No : 7499-07-2
In Stock
Synonyms
4-Chloro-2-methylbenzoic acid
4-Chloro-2-methylbenzoic acid